Svb Leerink upgraded shares of Nextgen Healthcare (NASDAQ:NXGN) from a market perform rating to an outperform rating in a report published on Thursday morning, BenzingaRatingsTable reports. The brokerage currently has $22.00 price objective on the stock, up from their previous price objective of $19.00. Svb Leerink also issued estimates for Nextgen Healthcare’s FY2021 earnings at $0.78 EPS.
Several other analysts have also recently issued reports on NXGN. Zacks Investment Research raised shares of Nextgen Healthcare from a sell rating to a hold rating in a research report on Monday, December 31st. Dougherty & Co raised shares of Nextgen Healthcare from a neutral rating to a buy rating and set a $19.00 price target on the stock in a research report on Friday, January 11th. Finally, Leerink Swann raised shares of Nextgen Healthcare from a market perform rating to an outperform rating in a research report on Thursday. One investment analyst has rated the stock with a sell rating, one has given a hold rating and five have given a buy rating to the stock. The stock currently has a consensus rating of Buy and a consensus target price of $19.50.
Shares of NXGN opened at $19.29 on Thursday. The stock has a market cap of $1.25 billion, a PE ratio of 33.84, a price-to-earnings-growth ratio of 3.21 and a beta of 1.15. Nextgen Healthcare has a 1 year low of $13.17 and a 1 year high of $23.73. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.31 and a current ratio of 1.32.
Nextgen Healthcare Company Profile
NextGen Healthcare, Inc provides software, services, and analytics solutions to medical and dental group practices in the United States. The company's principal products include NextGen Enterprise EHR, which stores and maintains clinical patient information; and a workflow module, prescription management, automatic document and letter generation, patient education, referral tracking, interfaces to billing and lab systems, physician alerts and reminders, and reporting and data analysis tools.
Featured Story: What is an overbought condition?
Receive News & Ratings for Nextgen Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nextgen Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.